From the Annual Meeting of the Consortium of MS Centers (CMSC), New Orleans

From Keith Edwards, MD   May 26, 2017 With the news of a MS patient in Germany who developed PML after 3 years of Tysabri and then one dose of ocrelizumab, the question of effectiveness and safety in ‘sequencing’ or switching from Tysabri (natalizumab) to another MS medication has become an even more important decision.  What… Read more »

Dr. Edwards and staff to attend CMSC, New Orleans

Dr. Edwards is the author/co-author on four posters – Accepted Abstracts  – at the CMSC Annual meeting in New Orleans, May 24-27. Karen Wesselhoeft, our nurse practitioner, has been accepted into the 9th Annual Linda Morgante Nurse Leadership Program from  May 22-24. Congratulations! Karen. Our infusion nurses, Samantha & Beverly are also attending the CMSC educational… Read more »